Skip to main content

Table 2 Multivariate analysis of OS and CSS of iPCN patients who underwent curative resection using the Cox proportional hazards model

From: Clinical characteristics and survival prediction of surgical patients with invasive pancreatic cystic neoplasm: a large retrospective study over two decades

Variables

OS

P value

CSS

P value

HR (95% CI)

HR (95% CI)

Age

  < 56

1 [reference]

 

1 [reference]

 

 56–75

1.330 (1.069–1.653)

0.010

1.193 (0.945–1.506)

0.137

  > 75

2.050 (1.599–2.627)

 < 0.001

1.650 (1.259–2.163)

 < 0.001

Sex

 Female

1 [reference]

 

1 [reference]

 

 Male

1.004 (0.860–1.173)

0.958

0.910 (0.767–1.080)

0.282

Race

 White

1 [reference]

 

1 [reference]

 

 Black

1.029 (0.788–1.345)

0.832

0.949 (0.699–1.290)

0.740

 Others

0.639 (0.482–0.848)

0.002

0.653 (0.476–0.895)

0.008

Histologic type

 iIPMN

1 [reference]

 

1 [reference]

 

 iMCN

0.836 (0.649–1.077)

0.165

0.901 (0.682–1.191)

0.464

 iSPN

0.034 (0.005–0.244)

 < 0.001

NA

NA

 iSCN

0.628 (0.086–4.562)

0.645

0.751 (0.103–5.479)

0.777

Pathological grade

 I

1 [reference]

 

1 [reference]

 

 II

1.521 (1.254–1.844)

 < 0.001

1.563 (1.254–1.947)

 < 0.001

 III–IV

2.114 (1.684–2.653)

 < 0.001

2.131 (1.655–2.743)

 < 0.001

Year of diagnosis

 2000–2008

1 [reference]

 

1 [reference]

 

 2009–2017

0.827 (0.701–0.976)

 < 0.025

0.785 (0.656–0.941)

0.009

Primary site

 Head

1 [reference]

 

1 [reference]

 

 Body and tail

1.105 (0.911–1.340)

0.312

1.045 (0.842–1.298)

0.690

 Others

0.924 (0.684–1.247)

0.603

0.952 (0.685–1.323)

0.769

Chemotherapy

 Yes

1 [reference]

 

1 [reference]

 

 No/unknown

1.218 (1.011–1.469)

0.038

1.045 (0.851–1.283)

0.674

Radiotherapy

 Yes

1 [reference]

 

1 [reference]

 

 No/unknown

1.075 (0.889–1.301)

0.455

1.147 (0.934–1.408)

0.190

Regional nodes examined

 0–7

1 [reference]

 

1 [reference]

 

 8–14

0.829 (0.686–1.003)

0.053

0.789 (0.639–0.973)

0.027

  > 14

0.667 (0.548–0.813)

 < 0.001

0.603 (0.484–0.751)

 < 0.001

T stage

 T1

1 [reference]

 

1 [reference]

 

 T2

1.388 (1.103–1.747)

0.005

1.458 (1.125–1.890)

0.004

 T3

1.309 (1.037–1.651)

0.023

1.266 (0.970–1.653)

0.083

 T4

3.176 (2.219–4.547)

 < 0.001

3.166 (2.139–4.688)

 < 0.001

N stage

 N0

1 [reference]

 

1 [reference]

 

 N1

2.081 (1.733–2.500)

 < 0.001

2.303 (1.881–2.821)

 < 0.001

 N2

2.822 (2.240–3.554)

 < 0.001

3.212 (2.500–4.129)

 < 0.001

M stage

 M0

1 [reference]

 

1 [reference]

 

 M1

1.624 (1.194–2.208)

0.002

1.749 (1.263–2.422)

 < 0.001

  1. Abbreviations: OS overall survival, CSS cancer-specific survival, iPCN invasive pancreatic cystic neoplasm, HR hazard ratio, iIPMN invasive intraductal papillary mucinous neoplasm, iMCN invasive mucinous cystic neoplasm, iSPN invasive solid pseudopapillary neoplasm, iSCN invasive serous cystic neoplasm